Clinical trial
Secretin for the Treatment of Autism
NCT00065962 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00065962 |
|---|---|
| Title | Secretin for the Treatment of Autism |
| Official title | Multisite Controlled Secretin Trial in Autism |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | National Institute on Deafness and Other Communication Disorders (NIDCD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | secretin, synthetic porcine, biologically derived porcine |
| Enrollment | 85 |
| Start date | Jun 1, 1999 |
| Completion | May 1, 2000 |
| First posted | Aug 5, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: